Device Registry Required to Determine Efficacy of Newest Prostate Cancer Treatment

Men diagnosed with prostate cancer in the United States now have another treatment option: high-intensity focused ultrasound (HIFU). However, the jury is out in terms of the effectiveness of the treatment, according to Weill Cornell Medicine researchers. In a paper published June 28 in JAMA, they recommend that registries should be created to generate the data and evaluate cancer control and safety.

Read full article.

Follow us on X

Check out our X feed for the latest news.

Population Health Sciences 575 Lexington Avenue | 425 E. 61st Street, 3rd Floor New York, NY Phone: (646) 962-8001